CytomX Therapeutics to Present Updates on CX-2009 at 2020 San Antonio Breast Cancer Symposium

NASDAQ Market News

NEXT STORY
Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combination With Cetuximab in Head and Neck Cancer at the ESMO Immuno-Oncology Virtual Congress
PREV STORY
Research From Exergen Corporation Shows Morning-Only Temperature Readings May Miss up to Half of All Fevers
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mersana Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage ...

author_avatar
NASDAQ Market News

Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous CONTEPO™ to Treat Complicated Urinary Tract Infections by FDA

-PDUFA action date set for June 30, 2019-DUBLIN, Ireland, Jan. 04, 2019 (GLOBE NEWSWIRE) ...

author_avatar
NASDAQ Market News

Curetis To Attend Key Investor and Scientific Conferences In The Second Quarter 2018

Curetis To Attend Key Investor and Scientific Conferences In The Second Quarter 2018 Amsterdam, ...

author_avatar
NASDAQ Market News